Clinical trial
Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With…
NCT00473616 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00473616 |
|---|---|
| Title | Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan |
| Official title | A Phase I Open-label, Multi-center, Dose-escalation and Safety Expansion Study to Assess Safety, Tolerability, and Pharmacokinectics of AZD7762 Administered as a Single Intravenous Agent and in Combination With Weekly Standard Dose of Irinotecan in Patients With Advanced Solid Malignancies. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Tumors, Cancer, Advanced Solid Malignancies |
| Intervention type | Drug |
| Interventions | AZD7762, Irinotecan |
| Enrollment | 60 |
| Start date | May 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | May 15, 2007 |
| Last update posted | Feb 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: